Goal Concordant Care Learning Laboratory
Sponsor
Duke University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05879211
Collaborator
(none)
5,000
2
25
Study Details
Study Description
Brief Summary
The goal-concordant care lab will develop and test strategies to optimize communication in advanced serious illness.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The goal-concordant care lab will develop and test strategies to optimize communication in advanced serious illness. The lab will test a variety of interventions, including triggered conversations and feedback to healthcare providers.
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
5000 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Several interventions will be tested, at the patient and provider levelsSeveral interventions will be tested, at the patient and provider levels
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Palliative Care Learning Laboratory
Anticipated Study Start Date
:
Jun 1, 2023
Anticipated Primary Completion Date
:
Jul 1, 2024
Anticipated Study Completion Date
:
Jul 1, 2025
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
No Intervention: Control Usual care |
|
Experimental: Intervention Feedback to provider regarding frequency and quality of communication |
Behavioral: Feedback
Providers will receive detailed feedback about the timing, quality, and frequency of their goals of care communication with patients
|
Outcome Measures
Primary Outcome Measures
- Frequency of goals of care communication [2 years]
Frequency of goals of care conversations in the last 6 months of life
- Timing of goals of care communication [6 months]
Proximity of goals of care communication to death
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Duke Health patient
Exclusion Criteria:
- None
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Duke University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT05879211
Other Study ID Numbers:
- Pro00106230
First Posted:
May 30, 2023
Last Update Posted:
May 30, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Duke University
Additional relevant MeSH terms: